Standard BioTools Inc (LAB)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash from Financing (Quarterly): -19.73M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -19.73M |
| December 31, 2023 | -1.003M |
| September 30, 2023 | -1.164M |
| June 30, 2023 | -2.084M |
| March 31, 2023 | -2.558M |
| December 31, 2022 | -0.27M |
| September 30, 2022 | -0.005M |
| June 30, 2022 | 212.96M |
| March 31, 2022 | 18.08M |
| December 31, 2021 | 7.297M |
| September 30, 2021 | 9.821M |
| June 30, 2021 | -0.133M |
| March 31, 2021 | -1.026M |
| December 31, 2020 | 0.432M |
| September 30, 2020 | 20.42M |
| June 30, 2020 | 0.511M |
| March 31, 2020 | -0.503M |
| December 31, 2019 | 1.784M |
| September 30, 2019 | -0.181M |
| June 30, 2019 | 1.04M |
| March 31, 2019 | 0.147M |
| December 31, 2018 | 59.95M |
| September 30, 2018 | -0.14M |
| June 30, 2018 | -2.094M |
| March 31, 2018 | -0.058M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.181M |
| September 30, 2017 | 28.86M |
| June 30, 2017 | -0.049M |
| March 31, 2017 | 0.003M |
| December 31, 2016 | -0.011M |
| September 30, 2016 | -0.007M |
| June 30, 2016 | 0.129M |
| March 31, 2016 | 0.005M |
| December 31, 2015 | 0.068M |
| September 30, 2015 | 0.144M |
| June 30, 2015 | 1.396M |
| March 31, 2015 | 3.732M |
| December 31, 2014 | 1.03M |
| September 30, 2014 | 0.627M |
| June 30, 2014 | 1.17M |
| March 31, 2014 | 197.50M |
| December 31, 2013 | 2.305M |
| September 30, 2013 | 1.081M |
| June 30, 2013 | 0.653M |
| March 31, 2013 | 1.767M |
| December 31, 2012 | -1.432M |
| September 30, 2012 | 54.12M |
| June 30, 2012 | -1.134M |
| March 31, 2012 | -3.038M |
| December 31, 2011 | -1.065M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-19.73M
Minimum
Mar 2024
212.96M
Maximum
Jun 2022
12.18M
Average
-0.069M
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | 151.70M |
| Azenta Inc | -74.07M |
| Harvard Bioscience Inc | -1.055M |
| Bionano Genomics Inc | -21.62M |
| Akoya Biosciences Inc | -0.444M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.48M |
| Cash from Investing (Quarterly) | 318.08M |
| Free Cash Flow | -99.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2151 |
| Free Cash Flow to Equity (Quarterly) | -54.70M |
| Free Cash Flow to Firm (Quarterly) | -63.26M |
| Free Cash Flow Yield | -30.30% |